Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "novel retinol dehydrogenase pseudogene" (ENSG00000258816) is a non-functional genomic locus derived from duplication events involving retinol dehydrogenases, specifically related to the human *RDHE2* and *RDHE2S (SDR16C6)* genes. While these related genes are members of the short-chain dehydrogenase/reductase (SDR) superfamily and function in vitamin A metabolism, the pseudogene itself has lost the ability to encode a functional protein due to sequence mutations and instability. No transcripts or protein products from this locus have been characterized as biologically significant in humans. Pseudogenes, including ENSG00000258816, are generally considered “genomic fossils” and do not encode active enzymes or contribute to physiological processes.
Not applicable; no mechanism of action, as no protein or function is present
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel retinol dehydrogenase pseudogene (ENSG00000258816).